UNSPSC 51334208: Quetiapine hemifumarate

This classification denotes a serotonin antagonist and antipsychotic agent with the molecular formula 2C21H25N3O2S.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2S3PL1B6UJ, chemically known as ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (e)-2-butenedioate (2:1), but more generally known as quetiapine hemifumarate, which bears US NIH Compound Identifier 5002.

European Medicines Agency schedules quetiapine hemifumarate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10192MIG. Most nations, for tariff purposes, schedule quetiapine hemifumarate under HS 29349990. SMILES: C1CCC2C(C1)C(=NC3CCCCC3S2)N4CCN(CC4)CCOCCO.C1CCC2C(C1)C(=NC3CCCCC3S2)N4CCN(CC4)CCOCCO.C(=C/C(=O)O)\C(=O)O.

UNSPSC 51334208 Quetiapine hemifumarate is a Commodity code that nominally describes a single pharmaceutical product, but the recent state and local opportunities tagged under it reveal that state and local governments actually procure much broader pharmaceutical supply across public health, agency benefit, and cooperative purchasing programs. The code shows activity in naloxone and drug deactivation systems procurement (community health support), direct-to-manufacturer prescription initiatives (state employee and retiree benefit optimization), and multi-source generic pharmaceutical and OTC product supply through cooperative purchasing agreements. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances administering procurement on behalf of member state and local facilities (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local government entities across Minnesota and Oregon).

Recent activity concentrates in Texas, Florida, and the upper Midwest. A representative opportunity is Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries and a two-year term with one-year renewal option. The Texas Health and Human Services Commission issued an RFI (HHS0017013, posted April 3, 2026) to gather vendor capabilities for a direct-to-manufacturer prescription program serving self-insured state employee and retiree plans. The Minnesota Multistate Cooperative Purchasing Alliance released RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers to participating state and local facilities, with awards effective July 1, 2026 and contract terms of two years for new vendors with optional extensions.